NIH-funded research U01 cooperative agreement

Testing new treatments to protect the brain after a stroke

Official title: Duke Testing Site for Stroke Preclinical Assessment Network

Funded at Duke University · NIH-11004370 · Data updated 2026-11-12

This study is looking at new ways to protect the brain during treatment for people who have had an ischemic stroke, using animal models to find the best options before trying them in humans, all to help improve recovery for stroke patients.

More Stroke research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startJanuary 15, 2023
Project endDecember 31, 2025
Funding year2025
Award (this year)$565,295
NIH project number5U01NS130598-03
Project IDNIH-11004370 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have suffered an ischemic stroke and are eligible for reperfusion therapy.

Less likely to help

Patients who have experienced hemorrhagic strokes or those who do not qualify for reperfusion therapy may not benefit from this research.

What this research studies

This research investigates effective cerebroprotective interventions that can be used alongside reperfusion therapy for patients who have experienced an ischemic stroke. By utilizing animal models, the study aims to assess the efficacy of these interventions in a controlled and blinded manner. The research is part of a larger initiative to improve long-term outcomes for stroke patients by identifying promising treatments before they are tested in humans. A multidisciplinary team at Duke University will conduct these assessments, leveraging their extensive experience in stroke research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and outcomes for stroke patients.

How similar studies have gone: Previous research has shown promise in developing cerebroprotective interventions, but this specific approach is part of a novel multi-site preclinical assessment initiative.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Sheng, Huaxin — Duke University
  • Study coordinator: Sheng, Huaxin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.